|1.||Klagsbrun, Michael: 7 articles (01/2011 - 01/2002)|
|2.||Tamagnone, Luca: 5 articles (03/2013 - 04/2007)|
|3.||Drabkin, Harry A: 4 articles (01/2014 - 05/2005)|
|4.||Roche, Joëlle: 4 articles (12/2013 - 01/2002)|
|5.||Staton, Carolyn A: 4 articles (05/2013 - 01/2010)|
|6.||Bielenberg, Diane R: 3 articles (11/2014 - 03/2006)|
|7.||Gemmill, Robert M: 3 articles (01/2014 - 05/2005)|
|8.||Nasarre, Patrick: 3 articles (01/2014 - 05/2005)|
|9.||Fowler, Ben: 3 articles (12/2010 - 07/2008)|
|10.||Maier, Julie: 3 articles (12/2010 - 07/2008)|
03/15/2009 - "As data continue to accumulate pointing to a role for neuropilins in cancer, the promise for targeting this pathway is beginning to unfold."
08/28/2015 - "The penetration was tumor-specific, circulation-independent, and mediated by the neuropilin-binding RXXK tissue-penetration peptide motif of iRGD. "
03/01/2014 - "Enhancement of the tumor penetration of monoclonal antibody by fusion of a neuropilin-targeting peptide improves the antitumor efficacy."
03/01/2013 - "Here we provide an overview of neuropilin function in neurons and neural crest cells, discuss current knowledge of neuropilin signalling in the vasculature and conclude with a summary of neuropilin roles in cancer."
01/01/2013 - "EGCG inhibits growth of human pancreatic tumors orthotopically implanted in Balb C nude mice through modulation of FKHRL1/FOXO3a and neuropilin."
|2.||Breast Neoplasms (Breast Cancer)
02/01/2010 - "Neuropilin transcript was below detection in substantial portion of the samples and was more frequently detected in high grade tumours (P=0.008 vs. low grade) and in tumours from patients who died of breast cancer (P<0.001 vs. those who remained disease-free). "
08/03/2004 - "VEGF165 binds to neuropilin, receptors for SEMA3B, and we found that SEMA3B competed for binding of 125I-VEGF165 to lung and breast cancer cells. "
07/28/2014 - "Structure-based discovery of a small non-peptidic Neuropilins antagonist exerting in vitro and in vivo anti-tumor activity on breast cancer model."
08/01/2011 - "This study aimed to identify the involvement of class 3 semaphorins (Sema3) and receptors, neuropilins (Np1 and Np2) and plexins (A1-A4) in breast cancer development and angiogenesis. "
01/01/2013 - "To quantify heterogeneity in angiogenesis-related gene expression in breast cancer, we focused on two families--VEGFs and semaphorins--that compete for neuropilin co-receptors on endothelial cells. "
|3.||Lung Neoplasms (Lung Cancer)
09/01/2015 - "Epigenetic targeting of the Neuropilin receptors may offer an effective treatment for lung cancer patients in the clinical setting."
12/01/2013 - "Here, we report that neuropilin (NRP)-2, the high-affinity receptor for SEMA3F and a coreceptor for certain growth factors, is upregulated during TGF-β1-driven EMT in lung cancer cells. "
05/01/2005 - "Although both antagonize VEGF binding/response to neuropilin (NRP) receptors, in lung cancer lines, SEMA3F is predominantly expressed and preferentially utilizes NRP2. "
|4.||Colonic Neoplasms (Colon Cancer)
02/01/2006 - "The preserved expression of neuropilin (NRP) 1 contributes to a better prognosis in colon cancer."
08/01/2006 - "In this study, transcripts encoding the VEGF-165 and semaphorin 3A (Sema3A) receptors and coreceptors Flt-1, KDR/Flk-1, plexin A1, and neuropilins NP-1 and NP-2 were identified by reverse transcription-PCR in the human colon cancer cell lines HCT8/S11, HT29, HCT116, and PCmsrc. "
|5.||Schizophrenia (Dementia Praecox)
|3.||Proteins (Proteins, Gene)
|6.||human VEGFA protein
|7.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|8.||Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
|10.||Vascular Endothelial Growth Factors